宜宾假体垫鼻子能保持多久宜宾哪里脱毛便宜,宜宾双眼皮整形手术的价格,宜宾有在做双眼皮的吗,宜宾硅胶隆胸手术多少钱,宜宾硅胶假体隆鼻价格表,宜宾玻尿酸去除黑眼圈,宜宾眼睛一单一双怎么办

The new PlayStation 5 is one of the hottest items this holiday season. A concrete block? Not so much.Nevertheless, a Utah man who thought he finally snagged Sony's new gaming system ended up receiving the latter.The Orem Police Department said the unidentified (for good reason) 38-year-old man ordered the PS5 from eBay for 8. Despite the systems selling for just 9 in stores, due to limited supplies and heavy demand, the second-hand price would not be considered exorbitant.When the package finally arrived at his Utah doorstep, the man found a new PlayStation 5 box inside. But inside that box was not the latest in gaming technology, but a big chunk of concrete. Talk about getting a lump of coal in your stocking!Police say the man should get his money back thanks to eBay's buyer/seller protections, but warn others to be cautious when buying items from sellers who have zero feedback scores. This article was written by Jeff Tavss for KSTU. 977

Milwaukee County completed its portion of Wisconsin’s partial presidential recount Friday night after the Milwaukee County Board of Canvassers certified the results.Milwaukee County ultimately recounted nearly 460,000 votes. President-elect Joe Biden gained 257 votes and President Donald Trump added 125 votes compared to Milwaukee County’s official canvass results. Biden netted an additional 132 votes to his margin of victory in Wisconsin, but Dane County’s recount has yet to finish.All that stood in the way of completing Milwaukee County’s recount Friday morning was 65 missing ballots from the city of Milwaukee. Those ballots were never found, so the board of canvassers decided to certify the results of all the other ballots in the county.Tens of thousands of ballots were separated during the recount at the Trump campaign’s request. 51,060 Milwaukee County voters self-certified that they were ‘indefinitely confined’ during the election. All of those voters who submitted their ballots had their ballot envelopes set aside for objections by Trump’s representatives.Additionally, 2,197 absentee ballot envelopes were separated because they had a different color ink on the witness address line, likely indicating clerks or poll workers filled in that missing information as allowed in the state.The board of canvassers decided that those votes would still count. The Trump campaign believes both categories could be fraudulent. Rick Bass, the only republican on the county’s 3-person board of canvassers, suggested those ballots will be subject to a Trump campaign legal challenge at a later date.“I trust that the Trump campaign is looking forward to its day in court,” commissioner Rick Baas said. “There were a number of things that had to be corrected and they’re often represented as just human error and usually they are. There are some things that couldn’t be examined, they’ll be examined at a different venue. This is not that place."Election officials said that no instances of fraud were found while conducting the recount.Dane County is expected to finish its presidential recount on Sunday.This article was written by WTMJ. 2169

You can only imagine the amount of times I thought about writing this. The way I would write it, how I would feel thereafter. Well, not entirely sure why now is the right time, and what it is that feels exciting and liberating for me to talk. I cannot explain it. Many of you wonder what happened to me, where did I disappear to and why. A journalist contacted me, he found a way to reach me and I told him everything this past summer. He was kind and it felt so amazing to finally speak. The truth is, and please trust me I am ok and safe now, I was raped and drugged and held captive over some days. Of course I survived. The recovery took time. There’s no light way to say it. But I can tell you in the last decade, the thousands and thousands of days I committed to wanting to feel the sunshine in my heart again, the sun does now shine. You wonder why I did not choose to use my voice to express my pain? I did not want to show the world the sadness in my eyes. I asked myself, how can I sing from the heart if it is broken? And slowly it unbroke. In the following weeks I will be posting a spoken interview. If you have any questions I would like to answer them, in the spoken interview, if I can. I have a sacred love and sincere appreciation for your kindness over the years. You have been friends. I want to thank you for that x Duffy Please respect this is a gentle move for me to make, for myself, and I do not want any intrusion to my family. Please support me to make this a positive experience. 1524

Oklahoma Governor Kevin Stitt announced at a news conference on Wednesday that he has tested positive for COVID-19. Stitt said the illnesses started as feeling achy, but reported no other symptoms. He is working from home and will remain in quarantine until Interim Commissioner of Health Lance Frye says it is okay to return.Stitt and Frye also gave an update on COVID-19 in Oklahoma. They said data showed that Oklahoma's positive rate is less than the national average for positive cases.Data also showed that hospitals have supplies stockpiled and the hospitalization rate in the state is going down. Oklahoma coronavirus cases are rising. The highest single-day total was reported on July 15 with 1,075 cases. As of July 14, a total of 432 Oklahomans have passed from the virus. Health officials urged Oklahomans to practice safety precautions by wearing a mask in public places, washing hands and practice social distancing.KJRH first reported this story. 982

INDIANAPOLIS — The U.S. Food and Drug Administration on Monday granted emergency use authorization to Eli Lilly and Company's experimental COVID-19 antibody treatment bamlanivimab.According to a statement from the company, the drug is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test who are at high risk for progressing to severe COVID-19 and/or hospitalization. Lilly said in a statement the drug should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion."This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients — adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic," David A. Ricks, Lilly's chairman and CEO, said. "The rapid development and availability of bamlanivimab could not have been achieved without the relentless work of our Lilly team, collaboration across the industry and the urgent work being done by the government to ensure appropriate allocation to patients who need it the most."The emergency use authorization is based on data from BLAZE-1, a randomized, double-blind, placebo-controlled Phase 2 study in patients with recently diagnosed mild to moderate COVID-19 in the outpatient setting. Patients treated with the drug showed reduced viral load and rates of symptoms and hospitalization, Lilly said in the statement. Infusion reactions and other allergic hypersensitivity events have been reported, Lilly said. The emergency use authorization includes a warning for hypersensitivity including anaphylaxis and infusion-related reactions.Lilly said the drug is not authorized for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy due to COVID-19 or who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity."The BLAZE-1 data show bamlanivimab, when given early in the disease course, may help patients clear the virus and reduce COVID-related hospitalizations, supporting our belief that neutralizing antibodies can be an important therapeutic option for patients fighting this virus," Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories, said. "We're proud of the speed with which we have been able to bring patients this therapy specifically designed to treat COVID-19. We thank those who have contributed to this medical advancement, particularly the clinical trial investigators and participants around the country." This article was written by Bob Blake for WRTV. 2906